In-depth coverage of the UK’s exit from the EU, and what it means to pharma and healthcare.
May sets out plans to leave single market, and aim for EU free trade deal
A look ahead to the UK market in 2017 through the eyes of pharma industry leaders
Moving EMA could slow approval process, warns Guido Rasi
Exclusive survey finds concerns about future of UK pharma industry
The UK government wants a ‘bespoke’ deal for pharma – but the EU has other ideas.
PM also promises corporation tax cuts and innovation investment
Soriot among first pharma leaders to comment on Trump victory